Enhanced infarct stabilization and neovascularization mediated by VEGF-loaded PEGylated fibrinogen hydrogel in a rodent myocardial infarction model

Biomaterials

Volumn 34, Issue 33, 2013, Pages 8195-8202

  Rufaihah, Abdul Jalil ^a   Vaibavi, Srirangam Ramanujam ^b   Plotkin, Marian ^b   Shen, Jiayi ^a   Nithya, Venkateswaran ^a   Wang, Jing ^a   Seliktar, Dror ^b,c   Kofidis, Theodoros ^a,d  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^d NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

Author keywords

Cardiac tissue engineering; Growth factors; Hydrogel; In vivo test

Indexed keywords

ANGIOGENIC GROWTH FACTORS; CARDIAC TISSUE ENGINEERING; CELLULAR MICROENVIRONMENT; GROWTH FACTOR; IN-VIVO TESTS; MYOCARDIAL INFARCTION; MYOCARDIAL PROTECTION; VASCULAR ENDOTHELIAL GROWTH FACTOR-A;

BIOLOGICAL MATERIALS; BIOMATERIALS; CELL ENGINEERING; ENDOTHELIAL CELLS; REPAIR; TISSUE ENGINEERING;

HYDROGELS;

BIOMATERIAL; FIBRINOGEN; MACROGOL; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOSYNTHESIS; CONTROLLED STUDY; CORONARY ARTERY LIGATION; FEMALE; HEART INFARCTION; HEART PERFORMANCE; HEART PROTECTION; HUMAN; HUMAN CELL; HYDROGEL; NONHUMAN; PRIORITY JOURNAL; RAT; RODENT; SIGNAL TRANSDUCTION; TISSUE ENGINEERING; TISSUE REGENERATION; TUMOR MICROENVIRONMENT;

RODENTIA;

CARDIAC TISSUE ENGINEERING; GROWTH FACTORS; HYDROGEL; IN VIVO TEST;

CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; ECHOCARDIOGRAPHY; FIBRINOGEN; HEMODYNAMICS; HUMANS; HYDROGEL; MYOCARDIAL INFARCTION; POLYETHYLENE GLYCOLS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84881662403     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.07.031     Document Type: Article

References (29)

1. Carmeliet P., Jain R.K. Molecular mechanisms and clinical applications of angiogenesis. Nature 2011, 473:298-307.
2. Potente M., Gerhardt H., Carmeliet P. Basic and therapeutic aspects of angiogenesis. Cell 2011, 146:873-887.
3. Hoeben A., Landuyt B., Highley M.S., Wildiers H., Van Oosterom A.T., De Bruijn E.A. Vascular endothelial growth factor and angiogenesis. Pharmacol Rev 2004, 54:549-580.
4. Almany L., Seliktar D. Biosynthetic hydrogel scaffolds made from fibrinogen and polyethylene glycol for 3D cell cultures. Biomaterials 2005, 15:2467-2477.
5. Gonen-Wadmany M., Goldshmid R., Seliktar D. Biological and mechanical implications of PEGylating proteins into hydrogel biomaterials. Biomaterials 2011, 32:6025-6033.
6. Lutolf M.P., Weber F.E., Schmoekel H.G., Schense J.C., Kohler T., Müller R., et al. Repair of bone defects using synthetic mimetics of collagenous extracellular matrices. Nat Biotechnol 2003, 21:513-518.
7. Moon J.J., Lee S.H., West J.L. Synthetic biomimetic hydrogels incorporated with Ephrin-A1 for therapeutic angiogenesis. Biomacromolecules 2007, 8:42-49.
8. Lutolf M.P., Hubbell J.A. Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nat Biotechnol 2005, 23:47-55.
9. Hahn M.S., Miller J.S., West J.L. Three-dimensional biochemical and biomechanical patterning of hydrogels for guiding cell behavior. Adv Mater 2006, 18:2679-2684.
10. Moon J.J., Hahn M.S., Kim I., Nsiah B.A., West J.L. Micropatterning of poly(ethylene glycol) diacrylate hydrogels with biomolecules to regulate and guide endothelial morphogenesis. Tissue Eng Part A 2009, 15:579-585.
11. Lin C.C., Anseth K.S. PEG hydrogels for the controlled release of biomolecules in regenerative medicine. Pharm Res 2009, 26:631-643.
12. Herrick S., Blanc-Brude O., Gray A., Laurent G. Fibrinogen. Int J Biochem Cell Biol 1999, 31:741-746.
13. Werb Z. ECM and cell surface proteolysis: regulating cellular ecology. Cell 1997, 91:439-442.
14. Lee R.J., Springer M.L., Blanco-Bose W.E., Shaw R., Ursell P.C., Blau H.M. VEGF gene delivery to myocardium: deleterious effects of unregulated expression. Circulation 2000, 102:898-901.
15. Horowitz J.R., Rivard A., van der Zee R., Hariawala M., Sheriff D.D., Esakof D.D., et al. Vascular endothelial growth factor/vascular maintenance role in quiescent adult endothelium. Arterioscler Thromb Vasc Biol 1997, 17:2793-2800.
16. Hariawala M.D., Horowitz J.R., Esakof D., Sheriff D.D., Walter D.H., Keyt B., et al. VEGF improves myocardial blood flow but produces EDRF-mediated hypotension in porcine hearts. JSurg Res 1996, 63:77-82.
17. Elbert D.L., Hubbell J.A. Conjugate addition reactions combined with free-radical cross-linking for the design of materials for tissue engineering. Biomacromolecules 2001, 2:430-441.
18. Dikovsky D., Bianco-Peled H., Seliktar D. Defining the role of matrix compliance and proteolysis in three-dimensional cell spreading and remodeling. Biophys J 2008, 94:2914-2925.
19. van Weel V., van Tongeren R.B., van Hinsbergh V.W., van Bockel J.H., Quax P.H. Vascular growth in ischemic limbs: a review of mechanisms and possible therapeutic stimulation. Ann Vasc Surg 2008, 22:582-597.
20. Zachary I., Morgan R.D. Therapeutic angiogenesis for cardiovascular disease: biological context, challenges, prospects. Heart 2011, 97:181-189.
21. Dikovsky D., Bianco-Peled H., Seliktar D. The effect of structural alterations of PEG-fibrinogen hydrogel scaffolds on 3D cellular morphology and cellular migration. Biomaterials 2006, 27:1496-1506.
22. Oss-Ronen L., Seliktar D. Polymer-conjugated albumin and fibrinogen composite hydrogels as cell scaffolds designed for affinity-based drug delivery. Acta Biomater 2011, 7:163-170.
23. Frisman I., Orbach R., Seliktar D., Bianco-Peled H. Structural investigation of PEG-fibrinogen conjugates. Acta Biomater 2010, 6:2518-2524.
24. Shapira-Schweitzer K., Habib M., Gepstein L., Seliktar D. Aphotopolymerizable hydrogel for 3-D culture of human embryonic stem cell-derived cardiomyocytes and rat neonatal cardiac cells. JMol Cell Cardiol 2009, 46:213-224.
25. Shapira-Schweitzer K., Seliktar D. Matrix stiffness affects spontaneous contraction of cardiomyocytes cultured within a PEGylated fibrinogen biomaterial. Acta Biomater 2007, 3:33-41.
26. Habib M., Shapira-Schweitzer K., Caspi O., Gepstein A., Arbel G., Aronson D., et al. Acombined cell therapy and in-situ tissue-engineering approach for myocardial repair. Biomaterials 2011, 32:7514-7523.
27. Carmeliet P. Angiogenesis in health and disease. Nat Med 2003, 9:653-660.
28. Koike N., Fukumura D., Gralla O., Au P., Schechner J.S., Jain R.K. Tissue engineering: creation of long-lasting blood vessels. Nature 2004, 428:138-139.
29. Wall S.T., Walker J.C., Healy K.E., Ratcliffe M.B., Guccione J.M. Theoretical impact of the injection of material into the myocardium: a finite element model simulation. Circulation 2006, 114:2627-2635.